Analyst Profile

Followed by 375 followers
.
Joseph Schwartz

Joseph Schwartz

SVB Securities
Wall Street Analyst
#8,034 out of 8,141 Wall Street Analysts
#23,820 out of 24,284 experts

Success Rate

32%
115 out of 356 transactions made a profit

Average Return

-17.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Joseph Schwartz's trades since 2009 and holding each position for 1 Year would result in 32.30% of your transactions generating a profit, with an average return of -17.4% per rating.

Stock Rating Distribution

975Ratings
86.97% Buy
12.21% Hold
0.82% Sell
Distribution of Joseph Schwartz's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
ChemoCentryx Inc
(CCXI)
Rating:Buy
Date:May 05, 2022 - Aug 05, 2022
Return:+223.00%
The most profitable rating made by Joseph Schwartz

Joseph Schwartz's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
MAPP
Map Pharmaceuticals
Jun 15, 2009
Buy
Upgraded
1Ratings
0.00%
HGSI
Human Genome Sciences
Nov 02, 2009
Buy
Reiterated
2Ratings
0.00%
SVNTQ
Savient Pharmaceuticals
May 05, 2011
Sell
Downgraded
2Ratings
0.00%
OMTH
Omthera
May 30, 2013
Hold
Downgraded
2Ratings
0.00%
VPHM
Viropharma
Aug 02, 2013
Hold
Downgraded
2Ratings
0.00%
~RNA
Prosensa Holding
Sep 20, 2013
Buy
Reiterated
2Ratings
0.00%
Amarin
Oct 30, 2013
Hold
Downgraded
6Ratings
0.00%
NPSP
NPS Pharma
May 09, 2014
Buy
Initiated
7Ratings
0.00%
Cytokinetics
May 19, 2014
Buy
Initiated
$8.00
(-80.32% Downside)
3Ratings
0.00%
GEVA
Synageva
Jul 02, 2014
Hold
Reiterated
4Ratings
0.00%
List of latest recommendations made by Joseph Schwartz. Click to expand and see Joseph Schwartz's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >